GGrantIndex
← Search

ACTG 351: PHASE I/II TRIAL OF CD4-IGG2 IN HIV-INFECTED C

$64,726M01FY2004RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →
ACTG 351: PHASE I/II TRIAL OF CD4-IGG2 IN HIV-INFECTED C · GrantIndex